These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 448576)

  • 21. A preliminary study on pharmacokinetics of oral indomethacin in premature infants in north India.
    Sharma PK; Garg SK; Narang A
    Indian J Med Res; 2003 Apr; 117():164-9. PubMed ID: 14604305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Duration of indomethacin treatment of the preterm patent ductus arteriosus as directed by echocardiography.
    Carmo KB; Evans N; Paradisis M
    J Pediatr; 2009 Dec; 155(6):819-822.e1. PubMed ID: 19643435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum indomethacin concentrations after intravenous administration to preterm infants with patent ductus arteriosus.
    Petersen S; Christensen NC; Møller Jensen K; Ryssing E
    Acta Paediatr Scand; 1981 Sep; 70(5):729-33. PubMed ID: 7324922
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of indomethacin on digoxin pharmacokinetics in preterm infants.
    Koren G; Zarfin Y; Perlman M; MacLeod SM
    Pediatr Pharmacol (New York); 1984; 4(1):25-30. PubMed ID: 6739184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of patent ductus arteriosus in preterm infants].
    Jaso E; Tejedor JC; Quero J; Pérez Rodríguez J; Agustí B; Castro J; García Frías E
    An Esp Pediatr; 1982 Jun; 16(6):449-58. PubMed ID: 7125398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Indomethacin-induced early patent ductus arteriosus closure cannot be predicted by a decrease in pulse pressure.
    Lubetzky R; Mandel D; Mimouni FB; Diamant S; Birger A; Barak M; Dollberg S
    Am J Perinatol; 2004 Jul; 21(5):257-61. PubMed ID: 15232757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [An alternative in the management of patent ductus arteriosus using indomethacin in premature newborn infants].
    Lozano González CH; Holden AM; Hurtado del Río D; Segura MA
    Bol Med Hosp Infant Mex; 1982 Aug; 39(8):570-5. PubMed ID: 7182006
    [No Abstract]   [Full Text] [Related]  

  • 28. Impact of patent ductus arteriosus and subsequent therapy with indomethacin on cerebral oxygenation in preterm infants.
    Lemmers PM; Toet MC; van Bel F
    Pediatrics; 2008 Jan; 121(1):142-7. PubMed ID: 18166568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics and clinical efficacy of indomethacin in premature infants with patent ductus arteriosus.
    Regazzi MB; Rondanelli R; Vidale E; Chirico G; Rondini G; Chiara A; Piccolo A
    Int J Clin Pharmacol Res; 1984; 4(2):109-12. PubMed ID: 6469435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness and side effects of an escalating, stepwise approach to indomethacin treatment for symptomatic patent ductus arteriosus in premature infants below 33 weeks of gestation.
    Sperandio M; Beedgen B; Feneberg R; Huppertz C; Brüssau J; Pöschl J; Linderkamp O
    Pediatrics; 2005 Dec; 116(6):1361-6. PubMed ID: 16322159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Indomethacin responsiveness of patent ductus arteriosus and renal abnormalities in preterm infants treated with indomethacin.
    Itabashi K; Ohno T; Nishida H
    J Pediatr; 2003 Aug; 143(2):203-7. PubMed ID: 12970633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment with intravenous indomethacin of symptomatic ductus arteriosus in premature newborn infants].
    Valls i Soler A; Benito J; Pastor E; López Heredia I; Santiago M; Cabrera A
    An Esp Pediatr; 1987 Aug; 27(2):112-6. PubMed ID: 3662265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Orogastric and intravenous indomethacin administration to very premature neonates with patent ductus arteriosus: population pharmacokinetics, absolute bioavailability, and treatment outcome.
    Al Za'abi M; Donovan T; Tudehope D; Woodgate P; Collie LA; Charles B
    Ther Drug Monit; 2007 Dec; 29(6):807-14. PubMed ID: 18043480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of indomethacin in the neonate. Relation of plasma indomethacin levels to response of the ductus arteriosus.
    Brash AR; Hickey DE; Graham TP; Stahlman MT; Oates JA; Cotton RB
    N Engl J Med; 1981 Jul; 305(2):67-72. PubMed ID: 7242577
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of oral ibuprofen and indomethacin therapy for patent ductus arteriosus in preterm infants.
    Fakhraee SH; Badiee Z; Mojtahedzadeh S; Kazemian M; Kelishadi R
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Oct; 9(5):399-403. PubMed ID: 17937843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Ibuprofen--a new application for pharmacological closure of patent ductus arteriosus in preterm infants. Preliminary report].
    Adamska E
    Med Wieku Rozwoj; 2000; 4(2 Suppl 3):65-71. PubMed ID: 11328971
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic closure of the ductus arteriosus: benefits and limitations.
    Mercanti I; Boubred F; Simeoni U
    J Matern Fetal Neonatal Med; 2009; 22 Suppl 3():14-20. PubMed ID: 19925358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Early closure of ductus arteriosus with indomethacin].
    Kääpä P
    Klin Padiatr; 1985; 197(2):172. PubMed ID: 3990156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of patent ductus arteriosus in preterm infants.
    Ekici F; Atasay B; Günlemez A; Naçar N; Tutar E; Atalay S; Eyileten Z; Uysalel A; Arsan S
    Anadolu Kardiyol Derg; 2006 Mar; 6(1):28-33. PubMed ID: 16524797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparison of the efficacy of ibuprofen and indomethacin in the treatment of patent ductus arteriosus in prematurely born infants].
    Adamska E; Helwich E; Rutkowska M; Zacharska E; Piotrowska A
    Med Wieku Rozwoj; 2005; 9(3 Pt 1):335-54. PubMed ID: 16547381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.